South Korean Medical Tourism Platform iipuda Secures ₩1 Billion for Global Expansion

The multilingual platform plans to strengthen its overseas marketing and expand partnerships in Japan, China, Taiwan and English-speaking markets.

South Korean medical tourism platform iipuda has secured approximately ₩1 billion—around US$650,000—in seed-stage funding as it prepares to expand its international patient acquisition activities.

The platform is operated by Kiip Corporation, a South Korean technology company connecting international patients with hospitals and clinics across the country. Its main treatment categories include plastic surgery, dermatology and dental care. International users can search for medical providers and request consultations directly through the platform.

The investment round attracted several domestic and international investors. Participants included Hong Kong-based Fantastic Wellness, the Busan Center for Creative Economy & Innovation, AX Ventures and artificial intelligence-focused investment company Unnoted.

Kiip Corporation had previously received pre-seed backing from Antler Korea. The company’s cumulative funding, including the earlier investment, has now reached approximately ₩1 billion.

Platform Reaches 10,000 Monthly Users

Since its official launch, iipuda has grown to approximately 10,000 monthly users and established partnerships with 35 medical institutions in South Korea.

The platform currently operates in four languages:

• English
• Japanese
• Traditional Chinese
• Simplified Chinese

This multilingual structure allows iipuda to target several of South Korea’s most important potential patient markets while reducing the communication barriers commonly faced by international patients.

Focus on Japan, China, Taiwan and English-Speaking Markets

Kiip Corporation plans to use the new capital to strengthen international marketing, attract more overseas users and develop partnerships in its priority markets.

The company is focusing particularly on Japan, Taiwan, mainland China and English-speaking countries. It also intends to expand its network of participating South Korean hospitals and clinics.

Kiip Corporation CEO Park Geon-su said the company would concentrate on growing both its international user base and its medical provider network, with the goal of creating a more transparent connection between South Korean healthcare providers and overseas consumers.

Digital Platforms Gain Importance in Korean Medical Tourism

The investment reflects growing interest in technology platforms that simplify the international patient journey.

Foreign patients often need to compare providers, communicate across language barriers and arrange consultations before travelling. Platforms such as iipuda aim to bring these activities into one digital system, allowing patients to discover clinics and begin the consultation process before arriving in South Korea.

For hospitals, these platforms can also provide a more structured channel for reaching international patients without relying entirely on traditional medical tourism agencies or independent referral partners.

Although iipuda remains an early-stage company, its funding round demonstrates that investors are paying greater attention to the infrastructure supporting cross-border healthcare—not only hospitals and medical procedures, but also the digital platforms responsible for patient discovery, communication and conversion.